ABBV SEC Filing News — AbbVie Inc.

Latest SEC filings for AbbVie Inc. (ABBV) explained in plain English. Covers insider buying and selling (Form 4), proposed insider sales (Form 144), material company events (8-K), and quarterly & annual reports (10-Q / 10-K). All data sourced directly from SEC EDGAR — last updated 2026-07-31.

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer. It also provides …
Sector: Healthcare Industry: Drug Manufacturers - General Market Cap: $443.4B CIK: 1551152
20
Total Filings
0
Bullish Signals
1
Bearish Signals
13
Insider Transactions
5
Material Events (8-K)
1
Periodic Reports
Insider activity for ABBV has skewed bearish recently. Of the 20 filings tracked, 1 carry bearish signals (such as insider sales or negative 8-K disclosures) versus 0 bullish. This does not necessarily signal fundamental deterioration — insiders sell for many reasons — but it is worth monitoring alongside the company's core financial metrics.
ABBV Filing Activity Snapshot 2026-04-29 — 2026-07-31
Insider Transactions (Form 4)
0 buys vs 0 sells
Insider buying and selling activity is balanced in this period.
Largest Transaction
$5.56M
ROBERT J ALPERN · 2026-05-26
13,000 shares · Form 144
Form 144 Notices
1
Proposed insider sale filed — Form 144 is a notice of intent, not a confirmed transaction. Actual sales are confirmed via Form 4.
Recent SEC Filings
Form 8-K Material Company Update 2026-07-31

ABBV filed 8-K — material company event

AbbVie Inc. filed an 8-K with the SEC reporting a material event. Filing excerpt: XBRL Viewer

Filing: 8-K (Material Event)
View on SEC EDGAR → Open Filing Document →
Form 8-K Material Company Update 2026-07-06

ABBV filed 8-K — material company event

AbbVie Inc. filed an 8-K with the SEC reporting a material event. Filing excerpt: XBRL Viewer

Filing: 8-K (Material Event)
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-07-02

ABBV insider Form 4 filed for equity award, exercise, or tax withholding

RAPP EDWARD J (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: RAPP EDWARD J (Director)
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-07-02

ABBV insider Form 4 filed for equity award, exercise, or tax withholding

Quaggin Susan E (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: Quaggin Susan E (Director)
View on SEC EDGAR → Open Filing Document →
Form 8-K Material Company Update 2026-06-22

ABBV filed 8-K — material company event

AbbVie Inc. filed an 8-K with the SEC reporting a material event. Filing excerpt: XBRL Viewer

Filing: 8-K (Material Event)
View on SEC EDGAR → Open Filing Document →
Form 144 Large Proposed Insider Sale 2026-05-26

ABBV Form 144 filed for proposed insider sale by ROBERT J ALPERN (13,000 shares) ~$5.56M

ROBERT J ALPERN filed a Form 144 with the SEC indicating intent to sell ABBV (AbbVie Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4. The proposed dollar value is large enough to merit attention.

Filing: Form 144 (Proposed Sale Notice) Insider: ROBERT J ALPERN Shares: 13,000 Est. Value: $5.56M
View on SEC EDGAR → Open Filing Document →
Form 8-K Material Company Update 2026-05-12

ABBV filed 8-K — material company event

AbbVie Inc. filed an 8-K with the SEC reporting a material event. Filing excerpt: XBRL Viewer

Filing: 8-K (Material Event)
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-05-12

ABBV insider Form 4 filed for equity award, exercise, or tax withholding

FALK THOMAS J (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: FALK THOMAS J (Director) Shares: 1,118
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-05-12

ABBV insider Form 4 filed for equity award, exercise, or tax withholding

WADDELL FREDERICK H (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: WADDELL FREDERICK H (Director) Shares: 1,118
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-05-12

ABBV insider Form 4 filed for equity award, exercise, or tax withholding

Roberts Rebecca B (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: Roberts Rebecca B (Director) Shares: 1,118
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-05-12

ABBV insider Form 4 filed for equity award, exercise, or tax withholding

RAPP EDWARD J (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: RAPP EDWARD J (Director) Shares: 1,118
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-05-12

ABBV insider Form 4 filed for equity award, exercise, or tax withholding

Quaggin Susan E (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: Quaggin Susan E (Director) Shares: 1,118
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-05-12

ABBV insider Form 4 filed for equity award, exercise, or tax withholding

MEYER MELODY B (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: MEYER MELODY B (Director) Shares: 1,118
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-05-12

ABBV insider Form 4 filed for equity award, exercise, or tax withholding

Hart Brett J (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: Hart Brett J (Director) Shares: 1,118
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-05-12

ABBV insider Form 4 filed for equity award, exercise, or tax withholding

FREYMAN THOMAS C (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: FREYMAN THOMAS C (Director) Shares: 1,118
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-05-12

ABBV insider Form 4 filed for equity award, exercise, or tax withholding

Davis Jennifer L. (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: Davis Jennifer L. (Director) Shares: 1,118
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-05-12

ABBV insider Form 4 filed for equity award, exercise, or tax withholding

BURNSIDE WILLIAM H.L. (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: BURNSIDE WILLIAM H.L. (Director) Shares: 1,118
View on SEC EDGAR → Open Filing Document →
Form 4 Tax / Compensation Filing 2026-05-12

ABBV insider Form 4 filed for equity award, exercise, or tax withholding

AUSTIN ROXANNE S (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Filing: Form 4 (Insider Transaction) Insider: AUSTIN ROXANNE S (Director) Shares: 1,118
View on SEC EDGAR → Open Filing Document →
Form 10-Q Quarterly Report 2026-05-08

ABBV filed Quarterly Report (10-Q)

AbbVie Inc. filed its quarterly report with the SEC. This report includes unaudited financial statements and management discussion for the quarter.

Filing: 10-Q (Quarterly Report)
View on SEC EDGAR → Open Filing Document →
Form 8-K Material Company Update 2026-04-29

ABBV filed 8-K — material company event

AbbVie Inc. filed an 8-K with the SEC reporting a material event. Filing excerpt: XBRL Viewer

Filing: 8-K (Material Event)
View on SEC EDGAR → Open Filing Document →

Understanding AbbVie Inc.'s SEC Filings

Form 4 — Insider Transactions

Executives, directors, and large shareholders must report any purchase or sale of ABBV shares within two business days. Consistent buying by multiple insiders is often read as a confidence signal; large sales may reflect diversification or liquidity needs rather than negative conviction.

Form 144 — Proposed Insider Sales

Filed when a company affiliate intends to sell restricted or control shares. A Form 144 is a notice of intent, not confirmation — the actual sale is later confirmed via Form 4. It gives investors advance visibility into planned insider selling activity.

8-K — Material Events

The 8-K is an event-driven filing that AbbVie Inc. must submit within four business days of a significant development — including earnings results, mergers, executive changes, credit facility updates, or regulatory actions. Each 8-K item code maps to a specific event type.

10-Q & 10-K — Periodic Reports

The 10-Q (quarterly) and 10-K (annual) are comprehensive reports covering AbbVie Inc.'s financial results, risk factors, management discussion, and business operations. The 10-K includes audited financials and is the most complete public disclosure the company makes each year.

Frequently Asked Questions — ABBV SEC Filings

What SEC filings does AbbVie Inc. submit to the SEC?

AbbVie Inc. (ABBV) submits several types of SEC filings including Form 4 (insider transactions), Form 144 (proposed insider sales), 8-K reports (material events such as earnings releases, acquisitions, leadership changes), and periodic reports — the 10-Q (quarterly) and 10-K (annual). All filings are publicly available through SEC EDGAR.

What does a Form 4 filing tell me about ABBV?

A Form 4 for ABBV discloses a transaction by a company insider — typically a director, officer, or 10%+ shareholder. It shows the date, number of shares bought or sold, the price, and the insider's updated total ownership. Consistent insider buying across multiple executives is often interpreted as a bullish signal.

How do I interpret an 8-K filing from AbbVie Inc.?

An 8-K signals a material event requiring prompt disclosure. Common triggers include earnings pre-announcements, acquisitions, leadership appointments or departures, credit changes, or regulatory actions. Read the item codes inside the filing to understand exactly what was disclosed before drawing conclusions.

What is the difference between a 10-K and 10-Q for ABBV?

The 10-K is AbbVie Inc.'s annual report with fully audited financial statements, comprehensive MD&A, and complete risk factor disclosures — filed 60–90 days after fiscal year-end. The 10-Q is a lighter quarterly report with unaudited financials filed for the first three quarters. Together they provide a continuous financial picture of the company.

Where can I see all ABBV SEC filings directly on EDGAR?

You can view all historical AbbVie Inc. filings on the SEC EDGAR company page for ABBV. Each filing card on this page links directly to the original SEC document.

How often does AbbVie Inc. file with the SEC?

AbbVie Inc. files one 10-K per year and up to three 10-Qs per year. Form 4 insider transactions must be reported within two business days of each trade, so the frequency depends on how often insiders are buying or selling ABBV shares. 8-K filings occur whenever a material event happens — which can be several times per quarter for an active company.

More Tools for ABBV

ABBV Full Stock Analysis ABBV Live Chart Institutional Ownership Earnings Calendar Options Flow Scanner Demand Zone Analyzer Sector Scanner Browse All Stocks

Want deeper ABBV analysis?

View valuation, growth metrics, AI Strong Buy score, demand zones, peer comparison, and more — all on the ABBV stock analysis page.

ABBV Full Analysis
SEC filing data is sourced from SEC EDGAR. This page is updated automatically as new filings are detected. Content is for informational purposes only and does not constitute investment advice. Full Disclaimer.